Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald S Falchook

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Journal of Immunotherapy and Precision Oncology|August 29, 2022
Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A reviewKavanya Feustel, Gerald S Falchook
Cell Cycle (Georgetown, Tex.)|April 7, 2015
VEGF and dual-EGFR inhibition in colorectal cancerGerald S Falchook, Razelle Kurzrock
Journal of Immunotherapy and Precision Oncology|April 11, 2025
B7 Homolog 4 (B7-H4)-Directed Agents in Oncology Clinical Trials: A ReviewMeave Phipps, Gerald S Falchook
Journal of Immunotherapy and Precision Oncology|May 9, 2024
T cell Immunoglobulin and Mucin Domain Containing Protein 3 (TIM-3) Inhibitors in Oncology Clinical Trials: A ReviewBenjamin Duong, Pratyush Banskota, Gerald S Falchook
Journal of Immunotherapy and Precision Oncology|February 8, 2024
B7-H3 Inhibitors in Oncology Clinical Trials: A ReviewKavanya Feustel, Jared Martin, Gerald S Falchook
Journal of Immunotherapy and Precision Oncology|March 28, 2025
4-1BB Antibodies in Oncology Clinical Trials: A ReviewRobin Schwartz, Keerti Vajrala, Gerald S Falchook
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
DabrafenibRadhika Kainthla, Kevin B Kim, Gerald S Falchook
Pharmacogenomics and Personalized Medicine|February 12, 2014
Dabrafenib for treatment of BRAF-mutant melanomaRadhika Kainthla, Kevin B Kim, Gerald S Falchook
Seminars in Oncology|November 29, 2015
Aurora Kinase Inhibitors in Oncology Clinical Trials: Current State of the ProgressGerald S Falchook, Christel C Bastida, Razelle Kurzrock
Investigational New Drugs|February 25, 2009
Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumorsTeresa G Hayes, Gerald S Falchook, Atul Varadhachary
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Journal of Immunotherapy and Precision Oncology|August 29, 2022
Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A reviewKavanya Feustel, Gerald S Falchook
Cell Cycle (Georgetown, Tex.)|April 7, 2015
VEGF and dual-EGFR inhibition in colorectal cancerGerald S Falchook, Razelle Kurzrock
Journal of Immunotherapy and Precision Oncology|April 11, 2025
B7 Homolog 4 (B7-H4)-Directed Agents in Oncology Clinical Trials: A ReviewMeave Phipps, Gerald S Falchook
Journal of Immunotherapy and Precision Oncology|May 9, 2024
T cell Immunoglobulin and Mucin Domain Containing Protein 3 (TIM-3) Inhibitors in Oncology Clinical Trials: A ReviewBenjamin Duong, Pratyush Banskota, Gerald S Falchook
Journal of Immunotherapy and Precision Oncology|February 8, 2024
B7-H3 Inhibitors in Oncology Clinical Trials: A ReviewKavanya Feustel, Jared Martin, Gerald S Falchook
Journal of Immunotherapy and Precision Oncology|March 28, 2025
4-1BB Antibodies in Oncology Clinical Trials: A ReviewRobin Schwartz, Keerti Vajrala, Gerald S Falchook
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
DabrafenibRadhika Kainthla, Kevin B Kim, Gerald S Falchook
Pharmacogenomics and Personalized Medicine|February 12, 2014
Dabrafenib for treatment of BRAF-mutant melanomaRadhika Kainthla, Kevin B Kim, Gerald S Falchook
Seminars in Oncology|November 29, 2015
Aurora Kinase Inhibitors in Oncology Clinical Trials: Current State of the ProgressGerald S Falchook, Christel C Bastida, Razelle Kurzrock
Investigational New Drugs|February 25, 2009
Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumorsTeresa G Hayes, Gerald S Falchook, Atul Varadhachary
Pageof 14